MedPath

Change in Airway Responsiveness After Allergen Exposure

Not Applicable
Completed
Conditions
Allergic Asthma
Interventions
Registration Number
NCT01699594
Lead Sponsor
University of Saskatchewan
Brief Summary

Exposure to allergens changes the way the airway responds to some stimuli (methacholine). The investigators will look at whether or not exposure to allergens changes the way the airway responds to a different stimuli (mannitol) and compare that with the known stimuli (methacholine).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
11
Inclusion Criteria
  • mild, allergic asthma
  • FEV1 greater than 70% predicted
  • methacholine PC20 less than or equal to 16mg/ml
Exclusion Criteria
  • known sensitivity to mannitol or other excipient
  • diagnosis of any other respiratory or non respiratory disease/disorder that would preclude the individual from participating
  • recent thoracic, abdominal or eye surgery
  • recent allergen exposure (4 weeks), respiratory infection (6 weeks)
  • current immunotherapy
  • pregnancy
  • history of anaphylaxis
  • use of asthma therapies other than short acting beta agonist

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
MannitolMannitolThis arm will assess the allergen induced change in airway responsiveness to mannitol bronchoprovocation.
Methacholine ChlorideMethacholine ChlorideThis arm will assess the allergen induced change in airway responsiveness to methacholine bronchoprovocation.
Primary Outcome Measures
NameTimeMethod
Change from baseline in airway responsiveness three hours after allergen exposureChange from Baseline at 3 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Saskatchewan

🇨🇦

Saskatoon, Saskatchewan, Canada

© Copyright 2025. All Rights Reserved by MedPath